gefitinib has been researched along with buthionine sulfoximine in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (buthionine sulfoximine) | Trials (buthionine sulfoximine) | Recent Studies (post-2010) (buthionine sulfoximine) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 2,460 | 8 | 408 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyazaki, N; Oda, S; Tsuneyama, K; Yokoi, T | 1 |
1 other study(ies) available for gefitinib and buthionine sulfoximine
| Article | Year |
|---|---|
Exacerbation of gefitinib-induced liver injury by glutathione reduction in mice.
Topics: Animals; Buthionine Sulfoximine; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP3A; Disease Progression; Gefitinib; Glutathione; Liver; Mice, Inbred C57BL; Oxidative Stress; Protein Kinase Inhibitors | 2020 |